Expertise in
12
conditions

Jin-hong H. Shin

Yangsan, KR 
Expertise in
12
conditions
Yangsan, KR 

Overview

Jin-hong Shin practices practicing medicine in Yangsan, Republic of Korea.

Shin is highly rated in 12 conditions, according to our data. Their clinical expertise encompasses X-Linked Infantile Nystagmus, Tubular Aggregate Myopathy, Duchenne Muscular Dystrophy, and X-Linked Myotubular Myopathy.

They are actively involved in clinical research, co-authoring 91 peer reviewed articles and participating in 5 clinical trials.

Locations

Yangsan, Republic of Korea
Other Locations
Suwon, Republic of Korea
Busan, Republic of Korea
Daegu, Republic of Korea
Incheon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel(Neuronata-R® Inj.) in Patients With Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug, Biological
Study Drugs: Lenzumestrocel, Riluzole
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping
A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Eteplirsen
Study Phase: Phase 3
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
View 3 Less Clinical Trials

91 Total Publications

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.
Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.
Journal: Neurology
Published: May 15, 2026

Frequently Asked Questions about Jin-hong H. Shin

Is Jin-hong H. Shin a top-rated expert for X-Linked Infantile Nystagmus?

MediFind is an objective health platform that identifies experts based on real-world data. Jin-hong H. Shin is classified as an Advanced expert for X-Linked Infantile Nystagmus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jin-hong H. Shin participate in research or clinical trials?

Yes. Jin-hong H. Shin has published 91 articles and abstracts on conditions like X-Linked Infantile Nystagmus. You can view a list of Jin-hong H. Shin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shin's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 53 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile